Skip to main content
Premium Trial:

Request an Annual Quote

Caliper Files Counterclaims against Carestream

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences today filed counterclaims against Carestream Health and denied allegations Carestream made in a recent patent infringement suit it filed against Caliper.

Last month, Rochester, NY-based Carestream alleged in a suit that Caliper is infringing US Patent No. 7,734,325, titled, "Apparatus and Method for Multi-Modal Imaging," which was issued to the firm on June 8, 2010. Specifically, Carestream said that Caliper's IVIS Lumina XR Imaging System uses technology covered by the '325 patent.

Caliper today filed its answer to that complaint, denying all allegations that it is infringing the patent and that Carestream is due any damages. In addition, Caliper has asked the court to declare that it is not infringing the patent, that certain claims in the patent are invalid, and that Caliper is entitled to a judgment that those claims are invalid or unenforceable.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.